Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells
- PMID: 7551915
- DOI: 10.1089/scd.1.1995.4.159
Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells
Abstract
Scale-up of human hematopoietic cultures was previously described in continuously perfused systems with bone marrow mononuclear cells (BMMNC), yielding expansion of both progenitors and long-term culture-initiating cells (LTC-IC). We report here on the use of these systems for expansion of unprocessed whole BM cells (WBMC) and CD34-enriched cells. Density separation recovered 84% of CFU-GM and 65% of LTC-IC from WBMC. Subsequent CD34 selection recovered 17% of CFU-GM and 48% of LTC-IC from the MNC fraction. The unabsorbed (CD34-depleted) fraction contained 37% of CFU-GM and 38% of LTC-IC, accounting for most of the lost cells. WBMC, BMMNC, and CD34-depleted cells were each placed directly in bioreactors, whereas CD34-enriched cells were placed in bioreactors containing preformed irradiated stroma. After 14 days, an average of 3.82 x 10(7) (12.7-fold expansion), 3.54 x 10(7) (11.8-fold), 2.85 x 10(7) (9.5-fold), and 3.65 x 10(7) (1298-fold) total cells were obtained from bioreactors inoculated with WBMC, BMMNC, CD34-depleted, and CD34-enriched cells on stroma, respectively. These cultures yielded 1.64 x 10(5) (27.9-fold expansion), 1.69 x 10(5) (14.3-fold), 8.36 x 10(4) (13.0-fold), and 1.91 x 10(5) (41.4-fold) CFU-GM each, respectively. Cell recovery and expansion data were combined to determine the number of expanded CFU-GM obtained per ml of BM aspirate, allowing direct comparison of performance between the four culture inocula. WBMC generated 3.76 x 10(6) CFU-GM per ml BM aspirate, whereas MNC resulted in 1.42 x 10(6) CFU-GM. CD34-enriched cells (on irradiated stroma) gave 7.00 x 10(5) CFU-GM per ml BM aspirate, whereas CD34-depleted cells generated 4.97 x 10(5) CFU-GM. The high productivity from WBMC cultures was studied further and was found to be reproducible at different inoculum densities. WBMC cultures had elevated levels of endogenous EGF and PDGF production, which may have been responsible for the more extensive stromal development observed. Flow cytometric analysis showed that the final culture composition, with respect to T and B lymphocytes, monocytes, granulocytes, and erythrocytes, was not significantly affected by the inoculum composition and in all cases was comprised of multiple lineages. Therefore, each step in cell purification resulted in the loss of primitive and accessory cells, which in turn resulted in a net decrease in the number of expanded cells obtained per ml BM aspirate.
Similar articles
-
Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis.Stem Cells. 1997;15(4):305-13. doi: 10.1002/stem.150305. Stem Cells. 1997. PMID: 9253115
-
Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.Blood. 1995 Sep 1;86(5):1784-93. Blood. 1995. PMID: 7544642
-
Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors.Exp Hematol. 1996 Nov;24(13):1484-93. Exp Hematol. 1996. PMID: 8950231
-
Analysis of CD34-expressing cells in clinical practice.Vox Sang. 1998;74 Suppl 2:469-75. doi: 10.1111/j.1423-0410.1998.tb05459.x. Vox Sang. 1998. PMID: 9704484 Review.
-
CD34 cell separation: from basic research to clinical applications.Int J Clin Lab Res. 1995;25(3):121-7. doi: 10.1007/BF02592552. Int J Clin Lab Res. 1995. PMID: 8562973 Review.
Cited by
-
Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells.Tissue Eng Part C Methods. 2012 Feb;18(2):133-42. doi: 10.1089/ten.TEC.2011.0305. Epub 2011 Dec 28. Tissue Eng Part C Methods. 2012. PMID: 21933020 Free PMC article.
-
Ex vivo expansion of cord blood.Bone Marrow Transplant. 2009 Nov;44(10):673-81. doi: 10.1038/bmt.2009.284. Epub 2009 Oct 5. Bone Marrow Transplant. 2009. PMID: 19802023 Free PMC article. Review.
-
Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.Cytotechnology. 1999 Jul;30(1-3):227-34. doi: 10.1023/A:1008085932764. Cytotechnology. 1999. PMID: 19003372 Free PMC article.
-
Human adipose-tissue derived stromal cells in combination with hypoxia effectively support ex vivo expansion of cord blood haematopoietic progenitors.PLoS One. 2015 Apr 28;10(4):e0124939. doi: 10.1371/journal.pone.0124939. eCollection 2014. PLoS One. 2015. PMID: 25919031 Free PMC article.
-
Overcoming the barriers to umbilical cord blood transplantation.Cytotherapy. 2010 Apr;12(2):121-30. doi: 10.3109/14653240903440111. Cytotherapy. 2010. PMID: 20196692 Free PMC article.